ArticleOncology reports2020

Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair.

Zhuoyi Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.